ArticleJournal for immunotherapy of cancer2019

Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC

Jinyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.